Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
BMC Cancer
|
August 3, 2016
Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer
Brian Won, Isa Mambetsariev, Ravi Salgia
Journal of Perinatology : Official Journal of the California Perinatal Association
|
March 24, 2021
Migration of cyclohexanone and 3,3,5-trimethylcyclohexanone from a neonatal enteral feeding system into human milk
Preetha Prazad, Ramona Donovan, Brian Won, et al.
Oncotarget
|
September 8, 2016
Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer
Victoria Villaflor, Brian Won, Rebecca Nagy, et al.
Cureus
|
April 20, 2016
The Chicago Thoracic Oncology Database Consortium: A Multisite Database Initiative
Brian Won, George B Carey, Yi-Hung Carol Tan, et al.
Oncotarget
|
February 14, 2018
Clinical and molecular features of innate and acquired resistance to anti-PD-1/PD-L1 therapy in lung cancer
Shalin Shah, Kevin Wood, Brian Labadie, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
BMC Cancer
|
August 3, 2016
Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer
Brian Won, Isa Mambetsariev, Ravi Salgia
Journal of Perinatology : Official Journal of the California Perinatal Association
|
March 24, 2021
Migration of cyclohexanone and 3,3,5-trimethylcyclohexanone from a neonatal enteral feeding system into human milk
Preetha Prazad, Ramona Donovan, Brian Won, et al.
Oncotarget
|
September 8, 2016
Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer
Victoria Villaflor, Brian Won, Rebecca Nagy, et al.
Cureus
|
April 20, 2016
The Chicago Thoracic Oncology Database Consortium: A Multisite Database Initiative
Brian Won, George B Carey, Yi-Hung Carol Tan, et al.
Oncotarget
|
February 14, 2018
Clinical and molecular features of innate and acquired resistance to anti-PD-1/PD-L1 therapy in lung cancer
Shalin Shah, Kevin Wood, Brian Labadie, et al.
Page
of 1